A matched case-control study to assess the carbapenem-resistant Enterobacteriaceae infections among hospitalized children at King Fahad Medical City, Riyadh, Saudi Arabia

References

1. ↵
   1. Codjoe FS,
   2. Donkor ES

   (2017) Carbapenem resistance:a review. Med Sci (Basel) 6:pii:E1, doi:10.3390/medsci6010001.

   OpenUrlGoogle Scholar
2. 1. Bedenić B,
   2. Plečko V,
   3. Sardelić S,
   4. Uzunović S,
   5. GodičTorkar K

   (2014) Carbapenemases in gram-negative bacteria:laboratory detection and clinical significance. Biomed Res Int 2014:841951.

   OpenUrlGoogle Scholar
3. ↵
   1. Thapa P,
   2. Bhandari D,
   3. Shrestha D,
   4. Parajuli H,
   5. Chaudhary P,
   6. Amatya J,
   7. et al.

   (2017) A hospital based surveillance of metallo-beta-lactamase producing gram negative bacteria in Nepal by imipenem-EDTA disk method. BMC Res Notes 10:322.

   OpenUrlGoogle Scholar
4. ↵
   1. Lutgring JD,
   2. Limbago BM

   (2016) The problem of carbapenemase-producing-carbapenem-resistant-enterobacteriaceae detection. J Clin Microbiol 54:529–534.

   OpenUrlAbstract/FREE Full TextGoogle Scholar
5. ↵
   1. CDC. Carbapenem-resistant enterobacteriaceae in healthcare settings [Internet]

   Centers for Disease Control and Prevention, Updated 2015, Available from: https://www.cdc.gov/hai/organisms/cre/index.html. Accessed 2019 July 4.

   Google Scholar
6. ↵
   1. Ding B,
   2. Hu F,
   3. Yang Y,
   4. Guo Q,
   5. Huang J,
   6. Wang M

   (2015) Four carbapenem-resistant gram-negative species carrying distinct carbapenemases in a single patient. J Clin Microbiol 53:1031–1033.

   OpenUrlAbstract/FREE Full TextGoogle Scholar
7. ↵
   1. European Centre for Disease Prevention and Control. ECDC

   Antimicrobial resistance surveillance in Europe 2014 [Internet], Updated 2015, Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/antimicrobial-resistance-europe-2014.pdf. Accessed 2019 July 4.

   Google Scholar
8. ↵
   1. Jean SS,
   2. Lee NY,
   3. Tang HJ,
   4. Lu MC,
   5. Ko WC,
   6. Hsueh PR

   (2018) Carbapenem-resistant enterobacteriaceae infections:Taiwan aspects. Front Microbiol 9:2888.

   OpenUrlGoogle Scholar
9. ↵
   1. van Loon K,
   2. Voor In't Holt AF,
   3. Vos MC

   (2017) A systematic review and meta-analyses of the clinical epidemiology of carbapenem-resistant enterobacteriaceae. Antimicrob Agents Chemother 62.

   Google Scholar
10. ↵
    1. Centers for Disease Control and Prevention

    Carbapenem-resistant enterobacteriaceae (CRE) infection:Clinician FAQs, Updated 2015, Available from: https://www.cdc.gov/hai/organisms/cre/cre-clinicianfaq.html. Accessed 2019 July 4.

    Google Scholar
11. 1. Nicolas-Chanoine MH,
    2. Vigan M,
    3. Laouénan C,
    4. Robert J

    (2019) Risk factors for carbapenem-resistant enterobacteriaceae infections:a French case-control-control study. Eur J Clin Microbiol Infect Dis 38:383–393.

    OpenUrlGoogle Scholar
12. ↵
    1. Ling ML,
    2. Tee YM,
    3. Tan SG,
    4. Amin IM,
    5. How KB,
    6. Tan KY,
    7. et al.

    (2015) Risk factors for acquisition of carbapenem resistant enterobacteriaceae in an acute tertiary care hospital in Singapore. Antimicrob Resist Infect Control 4:26.

    OpenUrlGoogle Scholar
13. ↵
    1. Chiotos K,
    2. Han JH,
    3. Tamma PD

    (2016) Carbapenem-resistant enterobacteriaceae infections in children. Curr Infect Dis Rep 18:2.

    OpenUrlGoogle Scholar
14. ↵
    1. Chiotos K,
    2. Tamma PD,
    3. Flett KB,
    4. Naumann M,
    5. Karandikar MV,
    6. Bilker WB,
    7. et al.

    (2017) Multicenter study of the risk factors for colonization or infection with carbapenem-resistant enterobacteriaceae in children. Antimicrob Agents Chemother 61:e140.

    OpenUrlGoogle Scholar
15. ↵
    1. Yezli S,
    2. Shibl AM,
    3. Memish ZA

    (2015) The molecular basis of β-lactamase production in gram-negative bacteria from Saudi Arabia. J Med Microbiol 64:127–136.

    OpenUrlCrossRefPubMedGoogle Scholar
16. ↵
    1. Khan MA,
    2. Mohamed AM,
    3. Faiz A,
    4. Ahmad J

    (2019) Enterobacterial infection in Saudi Arabia:First record of Klebsiella pneumoniae with triple carbapenemase genes resistance. JIDC 13:334–341.

    OpenUrlGoogle Scholar
17. ↵
    1. Garbati MA,
    2. Sakkijha H,
    3. Abushaheen A

    (2016) Infections due to carbapenem resistant enterobacteriaceae among Saudi Arabian hospitalized patients:A matched case-control study. Biomed Res Int 2016:3961684.

    OpenUrlGoogle Scholar
18. ↵
    1. Centers for Disease Control and Prevention

    FAQs about choosing and implementing a CRE definition, Updated 2015, Available from: https://www.cdc.gov/hai/organisms/cre/definition.html. Accessed 2019 July 3.

    Google Scholar
19. ↵
    1. Huang SR,
    2. Liu MF,
    3. Lin CF,
    4. Shi ZY

    (2014) Molecular surveillance and clinical outcomes of carbapenem-resistant escherichia coli and klebsiella pneumoniae infections. J Microbiol Immunol Infect 47:187–196.

    OpenUrlCrossRefPubMedGoogle Scholar
20. ↵
    1. Díaz A,
    2. Ortiz DC,
    3. Trujillo M,
    4. Garcés C,
    5. Jaimes F,
    6. Restrepo AV

    (2016) Clinical characteristics of carbapenem-resistant klebsiella pneumoniae infections in Ill and colonized children in Colombia. Pediatr Infect Dis J 35:237–241.

    OpenUrlCrossRefGoogle Scholar
21. ↵
    1. Montagnani C,
    2. Prato M,
    3. Scolfaro C,
    4. Colombo S,
    5. Esposito S,
    6. Tagliabue C,
    7. et al.

    (2016) Carbapenem-resistant enterobacteriaceae infections in children:An Italian retrospective multicenter study. Pediatr Infect Dis J 35:862–868.

    OpenUrlCrossRefGoogle Scholar
22. ↵
    1. Chang YY,
    2. Chuang YC,
    3. Siu LK,
    4. Wu TL,
    5. Lin JC,
    6. Lu PL,
    7. et al.

    (2015) Clinical features of patients with carbapenem nonsusceptible klebsiella pneumoniae and escherichia coli in intensive care units:a nationwide multicenter study in Taiwan. J Microbiol Immunol Infect 48:219–225.

    OpenUrlCrossRefGoogle Scholar
23. ↵
    1. Wu PF,
    2. Chuang C,
    3. Su CF,
    4. Lin YT,
    5. Chan YJ,
    6. Wang FD,
    7. et al.

    (2016) High minimum inhibitory concentration of imipenem as a predictor of fatal outcome in patients with carbapenem non-susceptible Klebsiella pneumoniae. Sci Rep 6:32665.

    OpenUrlGoogle Scholar
24. ↵
    1. Memish ZA,
    2. Assiri A,
    3. Almasri M,
    4. Roshdy H,
    5. Hathout H,
    6. Kaase M,
    7. et al.

    (2015) Molecular characterization of carbapenemase production among gram-negative bacteria in saudi arabia. Microb Drug Resist 21:307–314.

    OpenUrlCrossRefPubMedGoogle Scholar